NeoSync TMS Treatment for Bipolar I Depression
Stopped early · Phase 2
Conditions studied: Major Depressive Episode, Bipolar Depression, Bipolar Disorder, Mood Disorders
In brief
This study is designed to evaluate the safety and preliminary efficacy of synchronized transcranial magnetic stimulation (sTMS) using the NeoSync EEG Synchronized TMS device (NEST) in subjects with Bipolar Disorder type I in a Major Depressive Episode. This is an open label study in which subjects will receive treatment 5 days per week for 6 weeks.
Key facts
- Study ID
- NCT02839798
- Run by
- Butler Hospital
- People needed
- 6
- Starts
- 2016-05-01
- Expected to finish
- 2018-11-19
- Last updated by the study team
- 2020-04-09
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Butler Hospital — Providence, Rhode Island, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.